Advertisement

Topics

Post Capital Partners LLC Company Profile

08:05 EST 17th December 2018 | BioPortfolio

Post Capital Partners (www.postcp.com) is a private investment firm that makes both minority growth and control investments in companies with a minimum of $10 million of revenue and $2 million of EBITDA. Post Capital primarily employs an “Executive-First” deal sourcing and investment strategy in which they pursue growth capital investments, management buyouts, and “Executive-First” platform searches. Based in New York City, Post Capital invests a committed capital fund with top-tier institutional and sophisticated private investors.


News Articles [1616 Associated News Articles listed on BioPortfolio]

M&As this week: Ampersand Capital Partners, Bioblast Pharma, Synteract

Ampersand Capital Partners has acquired and merged biomarker testing services provide Pacific Biomarkers into its existing portfolio company, NEOMED-LABS. The...Read More... The post M&As this we...

Pfizer partners with Bain Capital to launch new CNS therapy firm

Pfizer has partnered with private investment firm Bain Capital to launch a new company, Cerevel Therapeutics, for the development of...Read More... The post Pfizer partners with Bain Capital to launch...

Aleph Capital and Crestview Partners Agree to €260M Equity Funding Commitment in DARAG to ...

LONDON and NEW YORK, July 30, 2018 /PRNewswire/ -- Aleph Capital Partners LLP ("Aleph Capital") and Crestview Partners ("Crestview") have today announced that funds under Read more...

Abris Capital Partners vend Urgent Cargus, le nº 2 de la livraison express en Roumanie

VARSOVIE, Pologne, September 27, 2018 /PRNewswire/ -- Abris Capital Partners, gestionnaire de fonds de capital-investissement privé d'Europe centrale et de l'Est, a vendu 100 % Read more...

Medigene: Leerverkäufer GSA Capital Partners hat sich deutlich zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP verringert Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners....

Glilot Capital Partners Raises $110 Million for Its Third Fund

TEL AVIV, Israel, Oct. 15, 2018 /PRNewswire/ -- Glilot Capital Partners a Venture capital fund which invests in early-stage startups, has announced the closing of Read more...

Oversubscribed Series B brings $110mm to Precision BioSciences

Precision BioSciences (gene editing) raised $110mm through an oversubscribed Series B round. ArrowMark Partners led and was joined by new investors Franklin Templeton Investments, Cowen Healthcare Inv...

Medigene-Aktie: Short-Attacke von GSA Capital Partners geht weiter

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP stockt Netto-Leerverkaufsposition in Medigene-Aktien nun deutlicher auf: Die Leerverkäufer des Hedgefonds GSA Capital Partn....

PubMed Articles [1494 Associated PubMed Articles listed on BioPortfolio]

Is Informal Financial Aid Good for Health? Evidence from Kyrgyzstan, a Low-Income Post-Socialist Nation in Eurasia.

The importance of social capital and economic advantage for health is well established in literature. The relationship between health and social capital through informal financial aid is less understo...

'If I had not taken it HIVST kit home, my husband would not have come to the facility to test for HIV': HIV self-testing perceptions, delivery strategies, and post-test experiences among pregnant women and their male partners in Central Uganda.

HIV self-testing (HIVST) can improve HIV-testing rates in 'hard-to-reach' populations, including men. We explored HIVST perceptions, delivery strategies, and post-test experiences among pregnant women...

Sexual functioning and relationship satisfaction of partners of breast cancer survivors who receive internet-based sex therapy.

As part of a larger, randomized controlled trial, we evaluated longitudinally the sexual functioning and relationship satisfaction of 69 partners of breast cancer (BC) survivors who received internet-...

A Recovery Capital and Stress-Buffering Model for Post-deployed Military Parents.

We tested a recovery capital model for military families employing the After Deployment, Adaptive Parenting Tools (ADAPT) randomized control trial, a longitudinal preventive intervention study of 336 ...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Clinical Trials [3183 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [2287 Associated Companies listed on BioPortfolio]

Post Capital Partners LLC

Post Capital Partners (www.postcp.com) is a private investment firm that makes both minority growth and control investments in companies with a minimum of $10 million of revenue a...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. ...

More Information about "Post Capital Partners LLC" on BioPortfolio

We have published hundreds of Post Capital Partners LLC news stories on BioPortfolio along with dozens of Post Capital Partners LLC Clinical Trials and PubMed Articles about Post Capital Partners LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Post Capital Partners LLC Companies in our database. You can also find out about relevant Post Capital Partners LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record